Tenaya Therapeutics Inc (NASDAQ: TNYA) kicked off on Monday, up 3.39% from the previous trading day, before settling in for the closing price of $0.67. Over the past 52 weeks, TNYA has traded in a range of $0.36-$4.01.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -15.48% over the past five years. While this was happening, its average annual earnings per share was recorded 38.25%. With a float of $134.18 million, this company’s outstanding shares have now reached $162.66 million.
Let’s look at the performance matrix of the company that is accounted for 97 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Tenaya Therapeutics Inc (TNYA) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Tenaya Therapeutics Inc is 17.51%, while institutional ownership is 27.55%. The most recent insider transaction that took place on May 16 ’25, was worth 615. In this transaction SVP, Finance of this company sold 1,390 shares at a rate of $0.44, taking the stock ownership to the 98,300 shares. Before that another transaction happened on May 16 ’25, when Company’s Chief Medical Officer sold 2,937 for $0.44, making the entire transaction worth $1,300. This insider now owns 171,856 shares in total.
Tenaya Therapeutics Inc (TNYA) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 38.25% per share during the next fiscal year.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Trading Performance Indicators
Take a look at Tenaya Therapeutics Inc’s (TNYA) current performance indicators. Last quarter, stock had a quick ratio of 6.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.16, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Tenaya Therapeutics Inc (TNYA)
Tenaya Therapeutics Inc (NASDAQ: TNYA) saw its 5-day average volume 2.24 million, a negative change from its year-to-date volume of 2.81 million. As of the previous 9 days, the stock’s Stochastic %D was 11.77%.
During the past 100 days, Tenaya Therapeutics Inc’s (TNYA) raw stochastic average was set at 56.49%, which indicates a significant increase from 16.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0806 in the past 14 days, which was higher than the 0.0569 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6435, while its 200-day Moving Average is $1.1703.
